Ocwen Financial Announces First Quarter 2023 Results
- Net loss of
$40 million , driven by a$39 million reduction in unrealized MSR fair value due to lower interest rates - Adjusted pre-tax income of
$6 million , driven by strong servicing performance - Achieved an annualized cost reduction of more than
$100 million versus Q2’22 baseline - Total liquidity of
$233 million as ofMarch 31, 2023 , an increase of 7% overDecember 31, 2022
The Company reported GAAP net loss of
Messina commented, “As we continue to execute our business strategy, we believe we are well-positioned to navigate the market environment ahead and deliver long-term value for our shareholders. Overall, I am proud of how our team is executing and excited about the potential for our business.”
Additional First Quarter 2023 Operating and Business Highlights
- Achieved a 12% cost reduction in Servicing and Overhead, and a 55% cost reduction in Originations compared to Q2’22 baseline
- Increased mix of higher margin products to 31% of owned MSR originations compared to 27% in Q4’22; expanded Correspondent Lending and Flow seller base by 8% compared to Q4’22
- Total servicing UPB of
$298 billion , up 3% compared to Q4’22 - Total subservicing UPB of
$162 billion , up 5% vs. Q4’22 - Since the upsize in
November 2022 ,MSR Asset Vehicle LLC (“MAV”) has purchased MSRs totaling$17 billion UPB at attractive pricing levels - Robust subservicing sales pipeline of over
$325 billion , as ofMarch 31, 2023 ;$30 billion subservicing additions targeted in remainder of 2023 - Entered into reverse subservicing contract with
Finance of America Reverse LLC - On
May 2, 2023 , the Court entered final judgment in Ocwen’s favor in theCFPB matter and closed the case - On
March 22, 2023 , S&P raised PHH’s forward servicer ratings from Average to Above Average and affirmed the ratings outlook as Stable - Book value per share of
$55 as ofMarch 31, 2023
Webcast and Conference Call
Ocwen will hold a conference call on
About
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by a reference to a future period or by the use of forward-looking terminology. Forward-looking statements are typically identified by words such as “expect”, “believe”, “foresee”, “anticipate”, “intend”, “estimate”, “goal”, “strategy”, “plan” “target” and “project” or conditional verbs such as “will”, “may”, “should”, “could” or “would” or the negative of these terms, although not all forward-looking statements contain these words, and includes statements in this press release regarding our growth opportunities. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Readers should bear these factors in mind when considering such statements and should not place undue reliance on such statements.
Forward-looking statements involve a number of assumptions, risks and uncertainties that could cause actual results to differ materially. In the past, actual results have differed from those suggested by forward looking statements and this may happen again. Important factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, but are not limited to, the impact of recent failures and re-organizations of banking institutions and continued uncertainty in the banking industry; the potential for ongoing disruption in the financial markets and in commercial activity generally as a result of international events, changes in monetary and fiscal policy, and other sources of instability; the impacts of inflation, employment disruption, and other financial difficulties facing our borrowers; our ability to timely reduce operating costs, or generate offsetting revenue, in proportion to the recent industry-wide decrease in originations activity; the impact of cost-reduction initiatives on our business and operations; uncertainty relating to the continuing impacts of the COVID-19 pandemic, including the response of the
Note Regarding Non-GAAP Financial Measures
This press release contains references to non-GAAP financial measures, such as our references to adjusted pre-tax income (loss) and adjusted expenses.
We believe these non-GAAP financial measures provide a useful supplement to discussions and analysis of our financial condition, because they are measures that management uses to assess the financial performance of our operations and allocate resources. In addition, management believes that these presentations may assist investors with understanding and evaluating our initiatives to drive improved financial performance. Management believes, specifically, that the removal of fair value changes of our net MSR exposure due to changes in market interest rates and assumptions provides a useful, supplemental financial measure as it enables an assessment of our ability to generate earnings regardless of market conditions and the trends in our underlying businesses by removing the impact of fair value changes due to market interest rates and assumptions, which can vary significantly between periods. However, these measures should not be analyzed in isolation or as a substitute to analysis of our GAAP expenses and pre-tax income (loss) nor a substitute for cash flows from operations. There are certain limitations to the analytical usefulness of the adjustments we make to GAAP expenses and pre-tax income (loss) and, accordingly, we use these adjustments only for purposes of supplemental analysis. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Ocwen’s reported results under accounting principles generally accepted in
Beginning with the three months ended
Beginning with the three months ended
Expense Notables
In the table titled “Expense Overview”, we adjust GAAP operating expenses for the following factors: compensation and benefit expenses related to severance, retention and other actions associated with cost and productivity improvement efforts; significant legal and regulatory settlement expense items(a); and certain other significant activities including, but not limited to, insurance related expense and settlement recoveries, compensation or incentive compensation expense or reversals attributable to stock price changes, and other expenses associated with significant transactions that are not attributable to or indicative of our ongoing operations, in order to offer additional visibility on underlying results and trends and provide investors with a supplemental means of evaluating our expenses, as evaluated by management.
(a) Including however not limited to
Expense Overview | ||||||||||||||||
($ in millions) | Q1'22 | Q4’22 | Q1’23 | |||||||||||||
I | Operating Expenses (as reported) | 127 | 120 | 114 | ||||||||||||
Adjustments for Notables(a) | ||||||||||||||||
Significant legal and regulatory settlement expenses | 5 | (1 | ) | (2 | ) | |||||||||||
Expense recoveries | 4 | (0 | ) | 0 | ||||||||||||
Severance and retention(b) | (1 | ) | (6 | ) | (4 | ) | ||||||||||
LTIP stock price changes(c) | 11 | (6 | ) | 2 | ||||||||||||
Office facilities consolidation | - | (1 | ) | (0 | ) | |||||||||||
Other(d) | (1 | ) | 1 | 0 | ||||||||||||
II | Expense Notables | 17 | (13 | ) | (4 | ) | ||||||||||
III | Expenses, net of Notables (I + II) | 144 | 107 | 110 |
(a) Certain previously presented notable categories with nil numbers for each quarter shown have been omitted; prior periods have been adjusted to conform with current period information
(b) Severance and retention due to organizational rightsizing or reorganization
(c) Long-term incentive program (LTIP) compensation expense changes attributable to stock price changes during the period
(d) Includes costs associated with strategic transactions including transaction costs related to the reverse subservicing acquisition from RMS(MAM), rebranding, and MAV upsize
Income Statement Notables
In the table titled “Income Overview” below, we show certain adjustments to GAAP pre-tax income (loss) for the following factors: Expense Notables, as detailed above; changes in fair value of our MSRs, Rithm and MAV Pledged MSR liability and ESS financing liability at fair value due to changes in market interest rates, valuation inputs and other assumptions, net of MSR hedge positions; changes in fair value of our reverse loans held for investment and HMBS related borrowings, net due to changes in market interest rates, valuation inputs and other assumptions; and certain other non-routine transactions, consistent with the intent of providing investors with a supplemental means of evaluating our pre-tax income/(loss), as evaluated by management.
Income Overview | |||||||||||||||
($ in millions) | Q1'22 | Q4’22 | Q1’23 | ||||||||||||
I | Reported Pre-Tax Income (Loss) | 61 | (79 | ) | (38 | ) | |||||||||
Adjustments for Notables(a) | |||||||||||||||
Expense Notables (from prior table) | (17 | ) | 13 | 4 | |||||||||||
Forward MSR Valuation Adjustments due to Rates and Assumption Changes, net(b)(d)(e) | (91 | ) | 72 | 46 | |||||||||||
Reverse Mortgage Fair Value Change due to Rates and Assumption Changes(c)(d) | 18 | (4 | ) | (7 | ) | ||||||||||
Other(f) | 1 | 1 | 1 | ||||||||||||
II | Total Income Statement Notables | (90 | ) | 83 | 44 | ||||||||||
III | Adjusted Pre-tax Income (Loss) (I + II) | (28 | ) | 4 | 6 |
(a) Certain previously presented notable categories with nil numbers for each quarter shown have been omitted; prior periods have been adjusted to conform with current period information
(b) MSR Valuation Adjustments that are due to changes in market interest rates, valuation inputs or other assumptions, net of overall fair value gains / (losses) on MSR hedge, including FV changes of Pledged MSR liabilities associated with MSR transferred to RITM and MAV that are due to changes in market interest rates, valuation inputs or other assumptions, a component of MSR valuation adjustment, net, the adjustment does not include valuation gains on MSR purchases of
(c) FV changes of loans HFI and HMBS related borrowings due to market interest rates and assumptions, a component of gain on reverse loans held for investment and HMBS-related borrowings, net
(d) The changes in fair value due to market interest rates were measured by isolating the impact of market interest rate changes on the valuation model output as provided by our third-party valuation expert
(e) Beginning with the three months ended
(f) Includes non-routine transactions
Consolidated Balance Sheet
Assets ($ in millions) | 2023 |
2022 |
2022 |
||
Cash and cash equivalents | 217 | 208 | 269 | ||
Restricted Cash | 39 | 66 | 76 | ||
Mortgage servicing rights, at fair value | 2,581 | 2,665 | 2,323 | ||
Advances, net | 657 | 719 | 730 | ||
Loans held for sale | 849 | 623 | 725 | ||
Loans held for investment | 7,669 | 7,511 | 7,459 | ||
Accounts receivable, net | 200 | 181 | 213 | ||
Investment in equity method investee | 37 | 42 | 35 | ||
Premises and equipment, net | 19 | 20 | 21 | ||
Other Assets | 359 | 364 | 446 | ||
Total Assets | 12,627 | 12,399 | 12,298 |
Liabilities & Stockholders’ Equity ($ in millions) | 2023 |
2022 |
2022 |
||
HMBS Related Borrowings | 7,471 | 7,327 | 7,119 | ||
Other Financing Liabilities | 1,153 | 1,137 | 872 | ||
Advance match funded liabilities | 470 | 514 | 497 | ||
Mortgage loan warehouse facilities | 948 | 703 | 959 | ||
MSR Financings, net | 915 | 954 | 893 | ||
Senior notes, net | 602 | 600 | 617 | ||
Other Liabilities | 653 | 709 | 807 | ||
Total Liabilities | 12,211 | 11,943 | 11,764 | ||
Total Stockholders’ Equity | 416 | 457 | 534 | ||
Total Liabilities and Stockholders’ Equity | 12,627 | 12,399 | 12,298 |
Consolidated Statement of Operations
($ in millions) | |||||||||||
Revenue | |||||||||||
Servicing and subservicing fees | 232 | 219 | 213 | ||||||||
Gain on reverse loans held for investment and HMBS-related borrowings, net | 21 | 19 | 13 | ||||||||
Gain on loans held for sale, net | 3 | 5 | (3 | ) | |||||||
Other Revenue, net | 6 | 7 | 9 | ||||||||
Total Revenue | 262 | 251 | 232 | ||||||||
MSR Valuation Adjustments, net | (69 | ) | (100 | ) | 35 | ||||||
Operating Expenses | |||||||||||
Compensation and benefits | 58 | 66 | 68 | ||||||||
Servicing and origination | 16 | 13 | 14 | ||||||||
Technology and communication | 13 | 14 | 15 | ||||||||
Professional services | 13 | 11 | 12 | ||||||||
Occupancy and equipment | 9 | 10 | 10 | ||||||||
Other expenses | 5 | 6 | 8 | ||||||||
Total Operating Expenses | 114 | 120 | 127 | ||||||||
Other Income (Expense) | |||||||||||
Interest income | 14 | 15 | 7 | ||||||||
Interest expense | (62 | ) | (60 | ) | (38 | ) | |||||
Pledged MSR liability expense | (70 | ) | (62 | ) | (60 | ) | |||||
Earnings of equity method investee | 0 | (1 | ) | 12 | |||||||
Other, net | 1 | (2 | ) | (0 | ) | ||||||
Total Other Income (Expense), net | (117 | ) | (110 | ) | (79 | ) | |||||
Income (loss) before income taxes | (38 | ) | (79 | ) | 61 | ||||||
Income tax expense (benefit) | 2 | 1 | 3 | ||||||||
Net Income (loss) | (40 | ) | (80 | ) | 58 |
For Further Information Contact:
(856) 917-0066
mediarelations@ocwen.com
Source: Ocwen Financial Corp.